Los registros los proporcionan patrocinadores e investigadores. Estar en el registro no garantiza seguridad, disponibilidad ni elegibilidad, ni representa un aval. Los títulos, resúmenes y criterios originales del registro se muestran en inglés para conservar su significado.
Listado de WCR consultado: 11 nov 2026.
ReclutandoNCT07867080
Diabetic Macular Edema (DME)
Fase 318 años - No especificadoScottsdale, Arizona, United States +84 A Phase 3, Randomized, Double-Masked, Active-Controlled Trial to Evaluate the Safety, Efficacy, and Durability of a Single Intravitreal Injection of 4D-150 versus Aflibercept in Adults with Diabetic Macular Edema (4SIGHT)
ReclutandoNCT06824467
Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer
Fase 318 años - No especificadoBirmingham, Alabama, United States +175 The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan with or without bevacizumab live longer without the cancer getting worse …
Por invitaciónNCT07842302
Multiple Sclerosis
No aplica18 años - No especificadoMadrid, Madrid, Spain Multiple Sclerosis (MS) is a chronic neurological disease impacting 2.8 million individuals globally, with fatigue being its most debilitating symptom, reported by 75% of patients. Despite its prevalence, the pathophysiology of MS-related fatigue rem…
Aún no reclutaNCT07469501
Opioid Use Disorder · Fentanyl
Fase 418 años - No especificadoSan Francisco, California, United States The goal of this pragmatic randomized controlled trial is to compare treatment outcomes of two strategies for initiating buprenorphine treatment (low-dose initiation and direct-to-inject) in adults with opioid use disorder (OUD) who use fentanyl. Thi…
ReclutandoNCT07549061
NSCLC (Advanced Non-small Cell Lung Cancer)
Fase 218 años - No especificadoShanghai, Shanghai Municipality, China To explore the efficacy and safety of vebreltinib plus platinum-doublet chemotherapy as first-line therapy in patients with driver mutation-negative, MET-overexpressing, PD-L1 TPS \< 50%, locally advanced or metastatic NSCLC .
ReclutandoNCT06942559
Obsessive Compulsive Disorder (OCD) · Treatment Resistant Obsessive Compulsive Disorder
No aplica18 años - 65 añosToronto, Ontario, Canada This trial aims to obtain initial evidence about the clinical efficacy and modulation of neurophysiological markers in obsessive compulsive disorder (OCD) using personalized (i.e., electroencephalography (EEG)-triggered) repetitive transcranial magne…
ReclutandoNCT07728903
Watching a Comedy Video
No aplica18 años - No especificadoMersin, Turkey, Turkey (Türkiye) +1 This study aims to determine the effects of watching a comedy video on anxiety, pain, procedural readiness, and uroflowmetric parameters in patients undergoing urodynamic testing. Data will be collected using the Descriptive Characteristics Form, Sta…
ReclutandoNCT07680790
Non-Small Cell Lung Cancer
Fase 318 años - No especificadoBeverly Hills, California, United States +179 The purpose of this study is to evaluate izalontamab brengitecan (iza-bren) combined with osimertinib in participants with previously untreated, locally advanced or metastatic EGFR-mutant NSCLC, compared to osimertinib alone or osimertinib combined w…
ReclutandoNCT04839705
Wide Neck Bifurcation Intracranial Aneurysms
No aplica18 años - No especificadoHollywood, Florida, United States +24 A prospective, multicenter, single arm, interventional study. The target patient population for this study are adult subjects with WNBAs of the anterior and posterior intracranial circulation. The primary effectiveness outcome of the study is adequat…
CompletadoNCT06800911
Obesity
Observacional18 años - 65 añosOggebbio, Verbania, Italy The study aims to investigate the presence of metacognitive beliefs, emotional regulation, and emotional eating in obese patients and their possible relationships.
CompletadoNCT06877234
Essential Hypertension
No aplica18 años - 65 añosGuangzhou, Guangdong, China This study is a prospective and exploratory clinical study, enrolling patients with essential hypertension. This study is planned to be conducted in 2 research institutions in China, and a total of 6 subjects are planned to be included. After the sub…
ReclutandoNCT02438904
Blood And Marrow Transplantation
No aplicaNo especificado - No especificadoHouston, Texas, United States Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).
Consultado en ClinicalTrials.gov: 11 nov 2026. El estado general puede ser distinto al de un centro específico.
